Background: The benefits of early abciximab administration and thrombus aspiration in ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI) have previously been elaborated. However, whether there is an adjunctive effect of thrombus aspiration among STEMI patients, with angiographic evidence of thrombus, receiving early prehospital abciximab remains unclear. You have free access to this content Journal of Interventional Cardiology Volume 25, Issue 1, Article first published online: 8 NOV 2011. Copyright © 2012, Wiley Periodicals, Inc. DOI: 10.1111/j.1540-8183.2011.00686.x.
The number of patients with cardiovascular implantable electronic devices (CIEDs), such as permanent pacemakers and implantable cardioverter-defibrillators, is dramatically rising due to an aging population and recent clinical trials showing benefits in mortality and morbidity. Coupled with this increase in the number of patients with CIEDs is the proliferation of technology that emits electromagnetic signals, which can potentially interfere with CIED function through electromagnetic interference (EMI). Despite continuous efforts of manufacturers to create “EMI-proof” CIEDs, adverse events from EMI still occur. Physicians caring for patients with CIEDs should be aware of potential sources of EMI and appropriate management options. This 2-part review aims to provide a contemporary overview of the current knowledge regarding risks attributable to EMI interactions from the most common nonmedical (Part I) and medical (Part II) Clinical Cardiology Volume 35, Issue 5, pages 276–280, May 2012. Article first published online: 26 APR 2012 DOI: 10.1002/clc.21998 Copyright © 2012 Wiley Periodicals, Inc.
Electromagnetic interference produced by medical equipment can interact with implanted cardiac devices such as pacemakers and implantable cardioverter-defibrillators. The most commonly observed interaction is in the operating room with electrosurgery. The risk of interactions can often be mitigated by close communication between the cardiac-device specialist and the anesthesiology/surgical team to develop a patient-specific strategy that accounts for factors such as type of device, type of surgery, and whether the patient is pacemaker dependent. Although magnetic resonance imaging should generally not be used in patients with implanted cardiac devices, several published guidelines provide strategies and recommendations for managing risks if magnetic resonance imaging is required with no suitable diagnostic alternatives. Other common sources of electromagnetic interference in the medical environment are ionizing radiation and left ventricular assist devices. Volume 35, Issue 6, pages 321–328, June 2012. Article first published online: 26 APR 2012. DOI: 10.1002/clc.21997 Copyright © 2012 Wiley Periodicals, Inc.
Objectives: This study sought to evaluate the ability of minimal luminal area (MLA) measured by intravascular ultrasound (IVUS) to assess the functional significance of coronary artery disease. Background: The use of IVUS to determine the functional significance of coronary artery lesions remains a matter for debate. JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, 2011. Copyright © 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00. PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.02.013.
Objectives: This study sought to develop a 2-dimensional (2D) intravascular near-infrared fluorescence (NIRF) imaging strategy for investigation of arterial inflammation in coronary-sized vessels. Background: Molecular imaging of arterial inflammation could provide new insights into the pathogenesis of acute myocardial infarction stemming from coronary atheromata and implanted stents. Presently, few high-resolution approaches can image inflammation in coronary-sized arteries in vivo. Journal of the American College of Cardiology Vol. 57, No. 25, 2011. Copyright © 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00. Published by Elsevier Inc. doi:10.1016/j.jacc.2011.02.036.
Objective: To study the impact of femoral compared to apical access on the Sapien-Edwards (SE) prosthesis deployment and geometry in patients treated with transcatheter aortic valve implantation (TAVI) for aortic stenosis. Background: SE prosthesis deformation exists after its deployment through transfemoral (TF - TAVI) approach. However, no study comparing the deformation between TF - TAVI and transapical (TA - TAVI) approaches has yet been published. You have free access to this content Journal of Interventional CardiologyVolume 25, Issue 1, Article first published online: 9 OCT 2011. Copyright © 2012, Wiley Periodicals, Inc. DOI: 10.1111/j.1540-8183.2011.00679.x.
Objectives: This study sought to assess, with optical coherence tomography (OCT), presumably culprit atherosclerotic lesions of saphenous vein grafts (SVGs) in patients with acute coronary syndromes (ACS). Background: Atherosclerotic lesions of SVGs have been studied in vivo with angioscopy and intravascular ultrasound. However, imaging with OCT, which has a higher resolution than intravascular ultrasound and better penetration than angioscopy, has not been conducted systematically. JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, 2011. Copyright © 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00. PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.02.015.
Background—Small stent area and residual inflow/outflow disease have been reported as the strongest intravascular ultrasound (IVUS) predictors of early stent thrombosis (ST) in patients with stable angina. IVUS predictors of early ST in patients with acute myocardial infarction have not been studied. Circulation: Cardiovascular Interventions. 2011; 4: 239-247 Published online before print May 17, 2011, doi: 10.1161. Copyright © American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 1941-7632
Aims To analyse the vasoreactivity of a coronary segment, previously scaffolded by the ABSORB bioresorbable vascular scaffold (BVS) device, in relationship to its intravascular ultrasound–virtual histology (IVUS–VH) composition and reduction in greyscale echogenicity of the struts. Coronary segments, transiently scaffolded by a polymeric device, may in the long-term recover a normal vasomotor tone. Recovery of a normal endothelial-dependent vasomotion may be enabled by scaffold bioresorption, composition of the underlying tissue, or a combination of both mechanisms. Published on behalf of the European Society of Cardiology. All rights reserved. Copyright © The Author 2012. European Heart Journal (2012) 33, 1325–1333 doi:10.1093/eurheartj/ehr466.
Atrial fibrillation (AF) is a common arrhythmia that can be found in normal individuals or reflect an underlying structural, metabolic, or infectious abnormality. Medical comorbidities associated with an increased risk for stroke in AF include age > 65 years, hypertension, rheumatic heart disease, prior stroke or transient ischemic attack, diabetes mellitus, congestive heart failure, or an abnormal transesophageal echocardiogram. In addition to beta blockade and cardioversion, formal anticoagulation with vitamin K antagonists, such as warfarin, remains the mainstay of therapy for AF in order to reduce the risk of systemic embolization.1 Drawbacks of warfarin therapy include a substantially increased risk of spontaneous intracranial hemorrhage, an entity all too familiar to most neurosurgeons. Neurosurgery: February 2012 - Volume 70 - Issue 2 - p N10–N11 doi: 10.1227/NEU.0b013e3181ae7dd2. Copyright © by the Congress of Neurological Surgeons
Aims: To compare the immediate and 18-month clinical and echocardiographic outcome of Inoue and multi-track system for balloon mitral valvuloplasty (BMV). You have free access to this content Journal of Interventional CardiologyVolume 25, Issue 1, Article first published online: 16 NOV 2011. Copyright © 2012, Wiley Periodicals, Inc. DOI: 10.1111/j.1540-8183.2011.00687.x.
Objectives: This study sought to assess the impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score (SXscore) on clinical outcomes in patients undergoing percutaneous coronary intervention. Background: The SXscore has been demonstrated to have an ability to predict clinical outcomes in patients undergoing percutaneous revascularization. Current studies are limited by the relatively small number of patients in each SXscore group. JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, 2011. Copyright © 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00. PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.02.018.
Objectives: Because fluorodeoxyglucose positron emission tomography (FDG-PET) imaging provides a noninvasive index of inflammation, we sought to assess whether FDG uptake in the aortic valve (AV) is increased in aortic stenosis (AS). Background: AS is associated with valvular inflammation. Journal of the American College of Cardiology Vol. 57, No. 25, 2011. Copyright © 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00. Published by Elsevier Inc. doi:10.1016/j.jacc.2010.12.046.
Background—Although in-stent restenosis (ISR) after bare-metal stent (BMS) implantation peaks in the early phase, very late (VL) ISR occasionally is observed beyond a few years after BMS implantation. To date, this mechanism has not been fully clarified. Circulation: Cardiovascular Interventions. 2011; 4: 232-238 Published online before print May 24, 2011, doi: 10.1161. Copyright © American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 1941-7632
Atrioventricular block (AVB) is a well-reported complication after closure of perimembranous ventricular septal defects (VSDs). To report the occurrence of AVB either during or following closure of perimembranous VSDs using a novel "hybrid" method involving a minimal inferior median incision and of intraoperative device closure of the perimembranous VSDs. BMC Cardiovascular Disorders Volume 12, Number 1 (2012), 21, DOI: 10.1186/1471-2261-12-21. Copyright © 2012 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos